-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on CVS Health, Lowers Price Target to $107

Benzinga·11/05/2026 18:34:41
Listen to the news
Barclays analyst Andrew Mok maintains CVS Health (NYSE:CVS) with a Overweight and lowers the price target from $108 to $107.